31 – 40 of 42
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors: analysis of HemoRec registry data from the Czech Republic
(
- Contribution to journal › Article
-
Mark
Could Spontaneous Retroperitoneal Haematoma Present with Scrotal Mass?
(
- Contribution to journal › Article
-
Mark
The plasma concentration of activated protein C appears normal in patients with haemophilia
(
- Contribution to journal › Article
-
Mark
Treatment and prevention of acute bleedings in von Willebrand disease--efficacy and safety of Wilate, a new generation von Willebrand factor/factor VIII concentrate.
(
- Contribution to journal › Article
-
Mark
Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A
(
- Contribution to journal › Article
- 2008
-
Mark
Genetic characterization of families with von Willebrand disease
(
- Thesis › Doctoral thesis (compilation)
- 2007
-
Mark
A systematic approach to controlling problem bleeds in patients with severe congenital haemophilia A and high-titre inhibitors
(
- Contribution to journal › Article
-
Mark
Interventional radiological management of prehepatic obstruction the splanchnic venous system
(
- Contribution to journal › Article
- 2006
-
Mark
Prophylaxis and treatment of bleeding complications in von Willebrand disease type 3.
(
- Contribution to journal › Article
-
Mark
Tyr2105Cys mutation in exon 22 of FVIII gene is a risk factor for the development of inhibitors in patients with mild/moderate haemophilia A
(
- Contribution to journal › Article